LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.0016667
 79.34 84.90 1200 9051 0.1326 0.4817
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 79.34 84.90 7156 9051 0.7906 0.9314
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 79.34 84.90 4819 9051 0.5324 0.8213
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 79.34 84.90 5314 9051 0.5871 0.8480
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 81.05 84.90 1140 8863 0.1286 0.4730
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 81.05 84.90 7322 8863 0.8260 0.9438
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 81.05 84.90 3760 8863 0.4242 0.7599
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 81.05 84.90 5305 8863 0.5985 0.8526
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 82.75 84.90 1275 8621 0.1479 0.5014
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 82.75 84.90 7640 8621 0.8862 0.9641
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 82.75 84.90 3115 8621 0.3613 0.7167
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 82.75 84.90 5338 8621 0.6192 0.8612
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 84.45 84.90 1319 8254 0.1598 0.5150
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 84.45 84.90 7825 8254 0.9479 0.9839
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 84.45 84.90 2582 8254 0.3128 0.6772
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 84.45 84.90 5291 8254 0.6410 0.8697
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 86.16 84.90 1344 8141 0.1651 0.5212
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 86.16 84.90 8143 8141 1.0001 1.0000
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 86.16 84.90 1625 8141 0.1996 0.5658
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 86.16 84.90 5263 8141 0.6464 0.8718
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 87.86 84.90 1386 7680 0.1805 0.5368
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 87.86 84.90 8393 7680 1.0928 1.0275
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 87.86 84.90 974 7680 0.1268 0.4556
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 87.86 84.90 5175 7680 0.6738 0.8821
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 89.57 84.90 1394 7494 0.1860 0.5418
MN20160318_Q02
K14